Gemin X Biotechnologies Inc. to Present at the 29th Annual Cowen Healthcare Conference
3/11/2009 9:42:57 AM
MALVERN, Pa. & MONTRÉAL--(BUSINESS WIRE)--Gemin X, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced that Glenn Gormley, M.D., Ph.D., president and chief executive officer of Gemin X, is scheduled to present at the 29th Annual Cowen Healthcare Conference being held at the Boston Marriott Copley Place in Boston, Massachusetts. Dr. Gormley’s presentation is scheduled for Wednesday, March 18, 2009 at 4:00 p.m. EDT.
comments powered by